CAS: 675590-04-2; 3-Bromo-5-(4-Fluorophenyl)Pyridine

该化合物是一种多用途溴化丙烯衍生物,在5号位置上有一个4-氟苯替代物,该化合物是制药和农用化学合成中有价值的中间体,特别是在铃木-宫浦的交叉反应中,由于其反应性溴性能,该化合物因其反应性反应性强而成为有机化学合成的重要中间体.用电子提取氟烯原子可增强化合物的稳定性和影响其电子特性,使其对生物活性分子的设计有用.其高纯度和定义明确的结构确保复杂的有机转化的可靠性能.该化合物的晶体形式有利于处理和储存,而其独特的分子结构则支持目标药物候选者和特殊化学品的开发.

结构式图片

相似化合物

142137-17-5 4422-32-6 1276123-21-7

上下游产品

3,5-dibromopyridine 4-fluoroboronic acid

合成工艺路线路线简述

    📜3,5-二溴吡啶,4-氟苯硼酸置于四(三苯基膦)钯,Sodium Carbonate体系中,用 乙醇,水,甲苯 作为反应溶剂,以66%的收率获得产物3-溴-5-(4-氟苯基)吡啶
    参考文献:Fine-Tuning The Selectivity Of Aldosterone Synthase Inhibitors: Structure−activity And Structure−selectivity Insights From Studies Of Heteroaryl Substituted 1,2,5,6-Tetrahydropyrrolo[3,2,1-Ij]Quinolin-4-One Derivatives
    标题:Fine-Tuning The Selectivity Of Aldosterone Synthase Inhibitors: Structure−activity And Structure−selectivity Insights From Studies Of Heteroaryl Substituted 1,2,5,6-Tetrahydropyrrolo[3,2,1-Ij]Quinolin-4-One Derivatives
    摘要:Pyridine Substituted 3,4-Dihydro-1H-Quinolin-2-Ones (E.G.,1-3) Constitute A Class Of Highly Potent And Selective Inhibitors Of Aldosterone Synthase (Cyp11B2),A Promising Target For The Treatment Of Hyperaldosteronism,Congestive Heart Failure,And Myocardial Fibrosis. Among These,Ethyl-Substituted 3 Possesses High Selectivity Against Cyp1A2. Rigidification Of 3 By Incorporation Of The Ethyl Group Into A 5-Or 6-Membered Ring Affords Compounds With A Pyrroloquinolinone Or Pyridoquinolinone Molecular Scaffold (E.G.,4 And 5). It Was Found That These Molecules Are Even More Potent And Selective Cyp11B2 Inhibitors Than Their Corresponding Open-Chain Analogues. Moreover,Pyrroloquinolinone 4 Exhibits No Inhibition Of The Six Most Important Hepatic Cyp Enzymes As Well As A Bioavailability In The Range Of The Marketed Drug Fadrozole. The Sar Studies Disclose That Subtle Changes In The Heterocyclic Moiety Are Responsible For Either A Strong Or A Weak Inhibition Of The Highly Homologous 11 Beta-Hydroxylase (Cyp11B1). These Results Are Not Only Important For Fine-Tuning The Selectivity Of Cyp11B2 Inhibitors But Also For The Development Of Selective Cyp11B1 Inhibitors That Are Of Interest For The Treatment Of Cushing'S Syndrome And Metabolic Syndrome.
    DOI:10.1021/jm101470K

    海关参考信息

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献

    参考DOI号:10.1021/jm101470k
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知